SHANGHAI – When Johnson & Johnson (J&J) set up its network of four Innovation Centers in the world's life science hot spots – Boston, California, London and Shanghai – it put into action a global experiment: Could a giant find a way to systematically engage in early stage possibilities in drugs, devices or consumer health with its innovative, entrepreneurial brethren? Having just announced 17 deals across the globe bringing the overall deal total to 200, they have shown if they fail, it won't be for lack of effort. Read More
Phagelux Inc., of Shanghai, said it entered definitive purchase agreements of preferred stock with a group of institutional investors, including both existing and new investors, to raise $10 million, with the company issuing an aggregate of 176,796 shares of series A preference stock. The company, which has both human health and agrihealth divisions, is developing antibacterial solutions across multiple fields utilizing various phage and phage-based technologies and solutions. Read More
HONG KONG – The discovery of a previously unknown autophagy defect associated with sarcopenia in mice could enhance the treatment or prevention strategies for managing the wasting condition in humans, suggest the findings of a study by Japanese researchers at Toyohashi University of Technology (TUT). Read More
A group of China-based investors is backing Bioatla LLC's bid to address growing demand for new immunotherapies in the country with a $30 million equity buy-in. Bioatla President, CEO and Chairman Jay Short called it a "transformative event" that will help the company leverage expertise at its established Beijing lab to build new strategic partnerships with Chinese biophama companies in pursuit of further developing its conditionally active biologic (CAB) antibody platform and other technologies. Read More
SHANGHAI – Inside Johnson & Johnson Innovation Center's 17-deal announcement, the Asia Pacific Innovation Center (APIC) shows it has been busy, too, signing four deals in the region: in Japan, Australia, Mainland China and Taiwan. Read More
